201 related articles for article (PubMed ID: 19223493)
21. [mRNA expression of IGF-IIand HGF in relation to microvascular density, tumor progression and prognosis of gastric carcinoma].
Zhao ZS; Ru GQ; Ma J
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):673-7. PubMed ID: 15777506
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth.
He XP; Shao Y; Li XL; Xu W; Chen GS; Sun HH; Xu HC; Xu X; Tang D; Zheng XF; Xue YP; Huang GC; Sun WH
FEBS J; 2012 Nov; 279(22):4201-12. PubMed ID: 23013439
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma.
Lin T; Ding YQ; Li JM
Med Oncol; 2012 Jun; 29(2):878-85. PubMed ID: 21336986
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
[TBL] [Abstract][Full Text] [Related]
25. c-Met expression in gastric cancer with liver metastasis.
Amemiya H; Kono K; Itakura J; Tang RF; Takahashi A; An FQ; Kamei S; Iizuka H; Fujii H; Matsumoto Y
Oncology; 2002; 63(3):286-96. PubMed ID: 12381909
[TBL] [Abstract][Full Text] [Related]
26. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Expression of Fatty Acid Synthase and Vascular Endothelial Growth Factor in Primary Colorectal Cancer: a Clinicopathological Study.
Mohamed AH; Said NM
J Gastrointest Cancer; 2019 Sep; 50(3):485-492. PubMed ID: 29681001
[TBL] [Abstract][Full Text] [Related]
28. Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer.
Endo M; Kanda M; Sawaki K; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Koike M; Omae K; Kodera Y
Anticancer Res; 2019 Nov; 39(11):5903-5910. PubMed ID: 31704814
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
30. Adverse prognosis of clustered-cell versus single-cell micrometastases in pN0 early gastric cancer.
Cao L; Hu X; Zhang Y; Huang G
J Surg Oncol; 2011 Jan; 103(1):53-6. PubMed ID: 21031429
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.
Yu GZ; Chen Y; Wang JJ
J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752
[TBL] [Abstract][Full Text] [Related]
32. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer.
Liu N; Zhang LH; Du H; Hu Y; Zhang GG; Wang XH; Li JY; Ji JF
Ann Surg Oncol; 2010 Oct; 17(10):2628-39. PubMed ID: 20383661
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.
Seo HM; Chang YS; Joo SH; Kim YW; Park YK; Hong SW; Lee SH
J Surg Oncol; 2009 Mar; 99(3):143-7. PubMed ID: 19117018
[TBL] [Abstract][Full Text] [Related]
35. Pathobiological significance of vascular endothelial growth factor and Maspin expressions in human gastric carcinoma.
Li JJ; Chen Y; Zhang SM; Wu DY; Wang YP; Xin Y
World J Gastroenterol; 2004 Sep; 10(18):2624-7. PubMed ID: 15309707
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
[TBL] [Abstract][Full Text] [Related]
37. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
38. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients.
Kumagai K; Yamamoto N; Miyashiro I; Tomita Y; Katai H; Kushima R; Tsuda H; Kitagawa Y; Takeuchi H; Mukai M; Mano M; Mochizuki H; Kato Y; Matsuura N; Sano T
Gastric Cancer; 2014 Apr; 17(2):273-80. PubMed ID: 23743877
[TBL] [Abstract][Full Text] [Related]
39. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
40. Correlation between chemosensitivity to anticancer drugs and Bcl-2 expression in gastric cancer.
Geng M; Wang L; Li P
Int J Clin Exp Pathol; 2013; 6(11):2554-9. PubMed ID: 24228120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
